Verified
I found the routine easier once I planned lunches instead of buying whatever was nearby. The main adjustment was reducing mayonnaise and cheese rather than skipping meals.
15 Sept 2026
Active ingredient: Orlistat
Alli
Quality products
24/7 Support
Fast delivery
Delivery
from 4 days
Alli is an oral medicine for weight management in adults who are overweight. Its key benefit comes from reducing the absorption of some dietary fat when used with a reduced-calorie, lower-fat diet.
Description
Alli is an oral weight-management medicine for adults who are overweight. It is used alongside a reduced-calorie, lower-fat diet to support weight loss by reducing the absorption of some dietary fat.
Composition
Alli is an oral weight-management medicine for adults who are overweight. It is used with a reduced-calorie, lower-fat diet, and the exact composition and other product details are stated on the pack.
Dosage and usage
Take the prescribed dose orally with water, immediately before, during, or within an hour after a main meal containing fat. Omit the meal-related dose if the meal is missed or contains no fat. Do not double a later dose to compensate.
The EMA’s administration principles also include:
- Spread dietary fat across meals. Saving most of the day’s fat for supper can increase digestive symptoms.
- Keep the diet nutritionally balanced. Lower-fat eating should still include vegetables, fruit, protein, and suitable sources of essential fats.
- Avoid extra doses after rich meals. More medicine does not cancel out overeating.
- Separate a daily multivitamin from Alli. A preparation containing vitamins A, D, E, and K should be taken at bedtime or at least two hours after Alli.
- Review progress rather than continuing indefinitely. The EMA treatment information limits a course to six months and calls for a review if weight has not fallen after twelve weeks.
Fat-soluble vitamins are vitamins absorbed with dietary fat. Reducing fat absorption can reduce their uptake, which is why vitamin timing matters.
A bedtime multivitamin is often easier to remember than arranging it around meals. Keep the required separation from Alli rather than taking both together with breakfast.
A missed dose does not require compensation.
How it works
Lipases are digestive enzymes that break dietary fat into smaller components so the intestine can absorb it. Alli inhibits these enzymes, leaving some fat undigested and allowing it to pass out in the stool.
The effect is specific to dietary fat. Calories from sugary drinks, alcohol, and most carbohydrate-rich foods remain available to the body. Someone can therefore eat relatively little fat and still consume more energy than they need.
This helps explain why a digestive medicine addresses only one part of weight management, rather than every driver of appetite or weight gain [2].
Indications
The European Medicines Agency describes Alli as a weight-management option for adults with a body mass index, or BMI, of at least 28. The U.S. Food and Drug Administration also lists orlistat among weight-management medicines. BMI relates weight to height; it helps identify a treatment group but does not measure body composition or explain every cause of weight gain. Alli’s benefit depends on a reduced-calorie diet and changes that can be maintained over time [1].
Alli suits a structured weight-management plan rather than occasional use after a large meal. It can add to diet-related weight loss, but its digestive effects make meal composition an important part of treatment.
Comparison
Weight-management treatments act through different pathways. The useful comparison is how each approach addresses eating, absorption, and long-term health—not simply which produces the largest change on the scales.
| Approach | Main action | Main practical limitation |
|---|---|---|
| Alli | Reduces absorption of some dietary fat | Fat-related bowel symptoms; requires attention to meals |
| Dietary and behavioural treatment | Changes energy intake, food choices, and routines | Requires sustained changes; hunger can remain difficult |
| GLP-1 receptor agonist treatment | Influences appetite and fullness | Requires separate clinical assessment; nausea and other gastrointestinal effects can occur |
Alli’s digestive action may appeal to someone seeking an oral approach without a direct appetite-suppressing effect. It is less suited to the expectation that medicine will remove hunger or prevent snacking.
Appetite-targeting medicines address a different problem. NICE guidance places weight-management medicines within a wider programme that includes dietary change, physical activity, and continuing review. These approaches are not automatically interchangeable, and treatment selection depends on the individual’s health, treatment history, and goals [3].
A lower-fat eating pattern can make Alli easier to tolerate. It cannot guarantee a particular weight-loss result.
Contraindications
Alli is not for you if you have chronic malabsorption syndrome, cholestasis, or an allergy to the medicine’s components.
It should also not be used:
- During pregnancy.
- While breastfeeding.
- With ciclosporin.
- With warfarin or other oral anticoagulants.
- By children or adolescents under the age covered by its adult indication.
Several other treatments need specific review before Alli is added. Reduced absorption can affect levothyroxine, antiepileptic medicines, amiodarone, and some HIV medicines.
When this is not for you
Do not use Alli if you have a condition that prevents your intestine from absorbing nutrients normally, impaired bile flow, or an allergy to its ingredients. It is not suitable during pregnancy or breastfeeding, for children or younger adolescents outside its adult indication, or if you take ciclosporin, warfarin, or another oral anticoagulant. Ask a clinician or pharmacist to review your medicines if you take thyroid treatment, seizure medicines, amiodarone, HIV treatment, or diabetes medicines, or if you have kidney disease.
Side effects
Alli’s most characteristic adverse effects involve the bowel. The EMA classifies several digestive reactions as very common, meaning they may affect more than one person in ten.
These include:
- Oily spotting or oily stools.
- Wind accompanied by discharge.
- A sudden need to pass a stool.
- Fatty stools.
- Soft stools.
Other possible effects include abdominal discomfort, more frequent bowel movements, and difficulty controlling bowel movements. Symptoms often become more noticeable after a meal containing a large amount of fat. They can also interfere with work, exercise, or travel.
Reducing meal fat is usually more useful than simply changing the time the medicine is taken. Persistent diarrhoea deserves attention because fluid loss can cause dehydration. Severe diarrhoea can also reduce the reliability of an oral contraceptive, making additional contraception necessary.
When bowel symptoms occur, record the meal and its added fats as well as the symptom. This can reveal a repeat trigger, such as creamy sauce or fried food, without unnecessarily restricting every food group.
Symptoms requiring prompt medical attention
Severe or persistent abdominal pain should not be dismissed as an expected digestive effect. Kidney stones, oxalate-related kidney injury, pancreatitis, and serious liver problems have been reported with this medicine class.
Seek urgent assessment for yellowing skin or eyes, dark urine with pale stools, severe abdominal pain, or markedly reduced urine output. Facial swelling, breathing difficulty, or a rapidly developing allergic reaction requires emergency care.
These warnings differ from ordinary oily stools. Their presence changes the response from meal adjustment to medical assessment.
Common mistakes
Most avoidable problems arise from misunderstanding what happens to dietary fat or treating a missed dose as something that must be recovered.
- Taking Alli after a fat-free meal. There is little dietary fat for its mechanism to act on.
- Doubling a dose. This does not make up for a missed meal-related dose.
- Using a high-fat meal to judge effectiveness. More oily discharge signals more unabsorbed fat, not better long-term weight loss.
- Ignoring drink calories. Sugary drinks and alcohol can undermine an energy deficit despite reduced fat absorption.
- Taking a multivitamin at the same time. This can interfere with absorption of fat-soluble vitamins.
- Stopping essential medicines without a plan. An interaction requires a treatment review, not an unsupervised interruption of thyroid, seizure, HIV, or anticoagulant treatment.
- Continuing without reviewing the outcome. Weight trend, tolerability, and nutritional intake all contribute to whether treatment remains useful.
Use comparable weigh-ins: the same scales, a similar time of day, and similar clothing. A trend is more informative than a single reading after a salty meal or a change in bowel habits.
What doctors say
A useful clinical assessment separates three questions: whether weight loss is appropriate, whether Alli’s mechanism suits the person’s eating pattern, and whether treatment is producing a worthwhile response.
A clinician will usually consider weight history, waist measurement, blood pressure, diabetes risk, medicines, and previous weight-management attempts. BMI is part of that assessment. It is not the whole assessment. Someone whose main difficulty is persistent hunger needs different expectations from someone whose meals regularly contain substantial fat. Digestive tolerability also matters because a treatment that repeatedly disrupts daily activities may be difficult to sustain. Progress should therefore include both weight change and the ability to maintain a balanced eating pattern.
The American Gastroenterological Association’s 2022 guideline did not favour routine use of orlistat, the medicine underlying Alli, because it judged the balance between modest benefit and gastrointestinal adverse effects unfavourable for many adults. That is a meaningful limitation, even though the EMA recognises a defined role for Alli [4].
The practical clinical message is measured: expect an additional contribution to weight loss, not a transformation independent of food intake.
Frequently asked questions
How quickly does Alli produce weight loss?
Its digestive action begins around the meals with which it is taken, but weight loss is assessed over weeks rather than hours. Early oily stools are not proof that meaningful weight loss has occurred. NICE’s 2025 weight-management guidance supports reviewing medicine use alongside dietary changes and treatment response. A consistent weight trend is more useful than day-to-day fluctuations.
Can Alli work without changing my diet?
Its mechanism can reduce absorption of some dietary fat, but it does not remove calories from every type of food or drink. High total energy intake can still prevent weight loss. WHO’s 2025 obesity information explains why weight management involves more than a single medicine or behaviour. A reduced-calorie, lower-fat diet is therefore part of treatment, not an optional extra.
Does Alli reduce appetite or stop cravings?
Alli works in the digestive tract rather than directly targeting the brain’s appetite pathways. Hunger, cravings, and habitual snacking can therefore continue. NICE’s 2025 guidance distinguishes medicines by their mechanisms and clinical roles. If hunger remains the main obstacle, treatment expectations need to account for that limitation.
Can I take Alli with a completely fat-free meal?
The meal-related dose is omitted when a meal contains no fat or is skipped. Taking an extra dose later does not compensate for that omission. The EMA’s 2009 assessment describes Alli as a treatment linked to fat-containing main meals. A balanced lower-fat diet is still preferable to eliminating all dietary fat.
Is Alli suitable for someone with diabetes?
Diabetes does not automatically rule it out, but glucose-lowering treatment needs consideration. Weight loss and changes in food intake can alter blood glucose and medicine requirements. NICE’s 2025 guidance places weight management within the person’s wider diabetes care. Insulin and other diabetes medicines should not be adjusted solely because Alli has been started.
Can Alli affect contraception?
Severe diarrhoea can reduce the reliability of an oral contraceptive even though Alli does not directly suppress contraceptive activity. Additional contraception is recommended when severe diarrhoea occurs. The EMA’s 2009 Alli assessment includes this practical warning. Ordinary oily spotting and severe diarrhoea are different symptoms, so describe the bowel change accurately when seeking advice.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Alli Current
Active ingredient: Orlistat
60mg
Contrave
98mg
Xenical
Active ingredient: Orlistat
120mg
60mg
Alli: Reviews and Experiences
4.3
Based on 4 reviews
Verified
I moved my multivitamin to bedtime because taking everything with breakfast had been my usual habit. Separating the routine was easier than I expected.
24 Sept 2026
Verified
I kept a record of my weight and meals instead of expecting a change every morning. It helped me notice the broader pattern without reacting to each daily fluctuation.
30 Sept 2026
Verified
A rich restaurant meal led to urgency the next day, which made work awkward. Lower-fat meals were easier to manage, but the digestive effects remained the part I liked least.
13 Oct 2026
Sources
- European Medicines Agency (2009). Alli: European Public Assessment Report.
- World Health Organization (2025). Obesity and overweight.
- National Institute for Health and Care Excellence (2025). Overweight and obesity management. NICE guideline NG246.
- American Gastroenterological Association (2022). AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity.
